Description
Food for medical use. Dietary food for maple syrup urine disease (MSUD) in children from 4 years and adults, including pregnant women (in combination with standard folic acid supplementation). To be used under medical supervision.
MSUD Lophlex LQ 10 is a leucine-, isoleucine- and valine-free liquid diet food based on amino acids, contains vitamins, trace elements and some minerals. Contains mixed fruit juices (from concentrate) and natural flavourings. With sugars and sweeteners. Contains docosahexaenoic acid (DHA).
MSUD Lophlex LQ 10 cannot be used as a sole source of nutrition, but must be given in combination with another protein source.
It is suitable as a diet food for MSUD in children from 4 years and adults.
- To be used only under medical supervision
- Only for use by patients with MSUD.
- Not suitable for parenteral use.
MSUD Lophlex LQ 10 is a food for medical use. Medical nutrition is recommended by a doctor or dietician.
*MSUD Lophlex LQ juicy berries may contain traces of leucine, isoleucine and valine (<1.5mg/100ml) from fruit juice (from concentrate).
Storage advice
Closed: Store cool and dry.
Open: Store in the refrigerator and use within 24 hours.
General information
One pack (62.5 ml) of MSUD Lophlex LQ 10 provides 10 grams of protein equivalent.
The daily dose of MSUD Lophlex LQ 10 must be determined by a doctor or dietician and depends on the age, weight and medical condition of the patient.
MSUD Lophlex LQ 10 is available from the pharmacy or a facility company.
Preparation
Shake MSUD Lophlex LQ 10 well before use and serve cool.
Packaging
One box contains 30 x 62.5 ml packets.
Item codes
126899
Compensation
MSUD Lophlex LQ 10 can be reimbursed by health insurance under certain conditions. Your doctor or dietician knows how he/she can apply for reimbursement and what the conditions are.
MSUD Lophlex LQ 10 is recommended by your doctor or dietician and is available from your pharmacy and/or facility company, depending on the conditions of your health insurer.
Reviews
There are no reviews yet.